Actor and comedian Will Forte is stepping into the spotlight to raise awareness about Huntington’s disease (HD), a rare and progressive neurological disorder that affects thousands of families across ...

Actor and comedian, Will Forte, opens up about his brother-in-law's journey with Huntington’s disease (HD) and chorea through ...

The drugmaker has recruited Will Forte, who appeared on “SNL” for nearly a decade in the aughts, perhaps most memorably as ...

Actor and comedian, Will Forte, opens up about his brother-in-law's journey with Huntington's disease (HD) and chorea through Teva's Honestly HD programHD is a rare, progressive genetic disorder often ...

By bringing attention to his brother-in-law’s journey as a Huntington’s disease patient, Forte is the latest ambassador for Teva’s Honestly HD campaign.

Will Forte advocates for people with Huntington’s disease.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of its Phase 2 clinical study of investigational ...

Neurocrine successfully developed and received U.S. Food and Drug Administration approval in 2017 for valbenazine, a selective VMAT2 inhibitor, for use as the first drug ever developed for the ...

The double-blind, placebo-controlled Phase II trial is enrolling approximately 100 adult participants with tardive dyskinesia ...

Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in local currency (LC) terms, compared ...